EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for GRML.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2022. Start Trial.
Date Value
June 30, 2026 -1.456
March 31, 2026 -7.392
December 31, 2025 -0.916
September 30, 2025 -2.436
June 30, 2025 -6.028
March 31, 2025 -3.846
December 31, 2024 -3.817
September 30, 2024 -8.866
June 30, 2024 -1.440
Date Value
March 31, 2024 -2.221
December 31, 2023 -0.418
September 30, 2023 -0.476
June 30, 2023 -0.8735
March 31, 2023 3.794
December 31, 2022 2.402
September 30, 2022 2.452
June 30, 2022 -0.7005
March 31, 2022 -0.017

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Tenax Therapeutics, Inc. -0.35
Manhattan Scientifics, Inc. --
Exicure, Inc. -0.1759
Century Therapeutics, Inc. -0.1679
Absci Corp. -0.2109

EPS Diluted (Quarterly) Related Metrics